Hemoglobin Oxygen Therapeutics LLC — Form D/A
Hemoglobin Oxygen Therapeutics LLC of SOUDERTON, PA, a company, filed a Form D amendment with the SEC on 2015-03-16. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-03-16
- Form: D/A
- Accession: 0001615647-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.3M
- Remaining: $20
- Minimum investment: $100K
- Investors: 3
- Date of first sale: 2014-07-22
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-222303
Issuer
- Name: Hemoglobin Oxygen Therapeutics LLC
- CIK: 0001615647
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 674 SOUDER ROAD, SOUDERTON, PA, 18964
- Phone: 267-382-0064
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Igor Borisovich Serov | Executive Officer | London, X0 |
| Zafiris George Zafirelis | Director | Needham, MA |
| Zafiris George Zafirelis | Executive Officer | Needham, MA |
| Gerald Raymond Kowalski | Director | Prague, 2N |
| Gerald Raymond Kowalski | Executive Officer | Prague, 2N |
Other filings by this issuer (2)
More